PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 114 filers reported holding PROVENTION BIO INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $400,687 | +71.7% | 16,626 | -24.7% | 0.00% | – |
| Q4 2022 | $233,407 | +181.2% | 22,082 | +19.5% | 0.00% | – |
| Q3 2022 | $83,000 | +62.7% | 18,482 | +44.1% | 0.00% | – |
| Q2 2022 | $51,000 | -38.6% | 12,830 | +12.5% | 0.00% | – |
| Q1 2022 | $83,000 | -25.9% | 11,400 | -43.0% | 0.00% | – |
| Q4 2021 | $112,000 | -12.5% | 20,000 | +0.1% | 0.00% | – |
| Q3 2021 | $128,000 | -12.9% | 19,975 | +14.6% | 0.00% | – |
| Q2 2021 | $147,000 | -16.0% | 17,425 | +4.7% | 0.00% | – |
| Q1 2021 | $175,000 | -32.7% | 16,641 | +8.6% | 0.00% | – |
| Q4 2020 | $260,000 | +32.0% | 15,321 | -0.4% | 0.00% | – |
| Q3 2020 | $197,000 | +38.7% | 15,384 | +52.9% | 0.00% | – |
| Q2 2020 | $142,000 | – | 10,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |